Thompson Travis Alvin, Chief Accounting Officer of Bicycle Therapeutics PLC ($BCYC), sold shares on the open market eight times in the last year, totaling $23,574. His most recent sale occurred on January 5, 2026. These sales rank him 10,953rd among nearly 12,000 insiders, far below the average of $8.6 million per seller and about six transactions. He made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 3, 2026 | BICYCLE THERAPEUTICS PLC | $BCYC | Thompson Travis Alvin | Chief Financial Officer | A | Employee Stock Option (right to buy) | 58000 | $0.00 | 58,000.0000 | 69,303,746 | 9999.99% | 0.08% |
| Jan. 2, 2026 | BICYCLE THERAPEUTICS PLC | $BCYC | Thompson Travis Alvin | CHIEF ACCOUNTING OFFICER | A | Employee Stock Option (right to buy) | 75000 | $0.00 | 75,000.0000 | 69,303,746 | 9999.99% | 0.11% |
| Jan. 2, 2026 | BICYCLE THERAPEUTICS PLC | $BCYC | Thompson Travis Alvin | CHIEF ACCOUNTING OFFICER | S | Ordinary Shares | 1317 | $6.80 | 67,380.0000 | 69,303,746 | 1.92% | 0.00% |
| Jan. 2, 2026 | BICYCLE THERAPEUTICS PLC | $BCYC | Thompson Travis Alvin | CHIEF ACCOUNTING OFFICER | A | Ordinary Shares | 37500 | $0.00 | 68,697.0000 | 69,303,746 | 120.20% | 0.05% |
| Jan. 5, 2026 | BICYCLE THERAPEUTICS PLC | $BCYC | Thompson Travis Alvin | CHIEF ACCOUNTING OFFICER | S | Ordinary Shares | 1115 | $6.45 | 66,265.0000 | 69,303,746 | 1.65% | 0.00% |
| Oct. 2, 2025 | BICYCLE THERAPEUTICS PLC | $BCYC | Thompson Travis Alvin | CHIEF ACCOUNTING OFFICER | S | Ordinary Shares | 221 | $8.40 | 31,300.0000 | 69,303,746 | 0.70% | 0.00% |
| Oct. 3, 2025 | BICYCLE THERAPEUTICS PLC | $BCYC | Thompson Travis Alvin | CHIEF ACCOUNTING OFFICER | S | Ordinary Shares | 103 | $8.41 | 31,197.0000 | 69,303,746 | 0.33% | 0.00% |
| July 2, 2025 | BICYCLE THERAPEUTICS PLC | $BCYC | Thompson Travis Alvin | CHIEF ACCOUNTING OFFICER | S | Ordinary Shares | 206 | $7.09 | 31,621.0000 | 69,252,009 | 0.65% | 0.00% |
| July 3, 2025 | BICYCLE THERAPEUTICS PLC | $BCYC | Thompson Travis Alvin | CHIEF ACCOUNTING OFFICER | S | Ordinary Shares | 100 | $7.44 | 31,521.0000 | 69,252,009 | 0.32% | 0.00% |
| April 2, 2025 | BICYCLE THERAPEUTICS PLC | $BCYC | Thompson Travis Alvin | CHIEF ACCOUNTING OFFICER | S | Ordinary Shares | 210 | $8.02 | 31,936.0000 | 69,196,945 | 0.65% | 0.00% |
| April 3, 2025 | BICYCLE THERAPEUTICS PLC | $BCYC | Thompson Travis Alvin | CHIEF ACCOUNTING OFFICER | S | Ordinary Shares | 109 | $7.48 | 31,827.0000 | 69,196,945 | 0.34% | 0.00% |
| Jan. 2, 2025 | BICYCLE THERAPEUTICS PLC | $BCYC | Thompson Travis Alvin | CHIEF ACCOUNTING OFFICER | A | Ordinary Shares | 17500 | $0.00 | 36,741.0000 | 58,207,593 | 90.95% | 0.03% |
| Jan. 2, 2025 | BICYCLE THERAPEUTICS PLC | $BCYC | Thompson Travis Alvin | CHIEF ACCOUNTING OFFICER | S | Ordinary Shares | 1750 | $14.09 | 34,991.0000 | 58,207,593 | 4.76% | 0.00% |
| Jan. 3, 2025 | BICYCLE THERAPEUTICS PLC | $BCYC | Thompson Travis Alvin | CHIEF ACCOUNTING OFFICER | S | Ordinary Shares | 159 | $14.75 | 34,832.0000 | 58,207,593 | 0.45% | 0.00% |
| Jan. 6, 2025 | BICYCLE THERAPEUTICS PLC | $BCYC | Thompson Travis Alvin | CHIEF ACCOUNTING OFFICER | S | Ordinary Shares | 2686 | $15.00 | 32,146.0000 | 58,207,593 | 7.71% | 0.00% |
| Jan. 2, 2025 | BICYCLE THERAPEUTICS PLC | $BCYC | Thompson Travis Alvin | CHIEF ACCOUNTING OFFICER | A | Employee Stock Option (right to buy) | 43500 | $0.00 | 43,500.0000 | 58,207,593 | 9999.99% | 0.07% |
| Nov. 11, 2024 | BICYCLE THERAPEUTICS PLC | $BCYC | Thompson Travis Alvin | CHIEF ACCOUNTING OFFICER | S | Ordinary Shares | 209 | $24.77 | 19,472.0000 | 68,988,858 | 1.06% | 0.00% |
| Nov. 11, 2024 | BICYCLE THERAPEUTICS PLC | $BCYC | Thompson Travis Alvin | CHIEF ACCOUNTING OFFICER | S | Ordinary Shares | 231 | $24.82 | 19,241.0000 | 68,988,858 | 1.19% | 0.00% |
| Nov. 11, 2024 | BICYCLE THERAPEUTICS PLC | $BCYC | Thompson Travis Alvin | CHIEF ACCOUNTING OFFICER | M | Employee Stock Option (right to buy) | 1312 | $0.00 | 2,617.0000 | 68,988,858 | 33.39% | 0.00% |
| Nov. 11, 2024 | BICYCLE THERAPEUTICS PLC | $BCYC | Thompson Travis Alvin | CHIEF ACCOUNTING OFFICER | M | Employee Stock Option (right to buy) | 154 | $0.00 | 302.0000 | 68,988,858 | 33.77% | 0.00% |
| Nov. 11, 2024 | BICYCLE THERAPEUTICS PLC | $BCYC | Thompson Travis Alvin | CHIEF ACCOUNTING OFFICER | M | Employee Stock Option (right to buy) | 1109 | $0.00 | 12,954.0000 | 68,988,858 | 7.89% | 0.00% |
| Nov. 11, 2024 | BICYCLE THERAPEUTICS PLC | $BCYC | Thompson Travis Alvin | CHIEF ACCOUNTING OFFICER | M | Ordinary Shares | 1312 | $1.87 | 24,234.0000 | 68,988,858 | 5.72% | 0.00% |
| Nov. 11, 2024 | BICYCLE THERAPEUTICS PLC | $BCYC | Thompson Travis Alvin | CHIEF ACCOUNTING OFFICER | S | Ordinary Shares | 1312 | $25.05 | 22,922.0000 | 68,988,858 | 5.41% | 0.00% |
| Nov. 11, 2024 | BICYCLE THERAPEUTICS PLC | $BCYC | Thompson Travis Alvin | CHIEF ACCOUNTING OFFICER | M | Ordinary Shares | 154 | $8.21 | 23,076.0000 | 68,988,858 | 0.67% | 0.00% |
| Nov. 11, 2024 | BICYCLE THERAPEUTICS PLC | $BCYC | Thompson Travis Alvin | CHIEF ACCOUNTING OFFICER | S | Ordinary Shares | 154 | $25.01 | 22,922.0000 | 68,988,858 | 0.67% | 0.00% |
| Nov. 11, 2024 | BICYCLE THERAPEUTICS PLC | $BCYC | Thompson Travis Alvin | CHIEF ACCOUNTING OFFICER | M | Ordinary Shares | 1109 | $9.82 | 24,031.0000 | 68,988,858 | 4.84% | 0.00% |
| Nov. 11, 2024 | BICYCLE THERAPEUTICS PLC | $BCYC | Thompson Travis Alvin | CHIEF ACCOUNTING OFFICER | S | Ordinary Shares | 1109 | $25.05 | 22,922.0000 | 68,988,858 | 4.61% | 0.00% |
| Nov. 11, 2024 | BICYCLE THERAPEUTICS PLC | $BCYC | Thompson Travis Alvin | CHIEF ACCOUNTING OFFICER | S | Ordinary Shares | 3241 | $25.21 | 19,681.0000 | 68,988,858 | 14.14% | 0.00% |
| Oct. 3, 2024 | BICYCLE THERAPEUTICS PLC | $BCYC | Thompson Travis Alvin | CHIEF ACCOUNTING OFFICER | S | Ordinary Shares | 153 | $22.26 | 22,922.0000 | 68,988,858 | 0.66% | 0.00% |
| July 3, 2024 | BICYCLE THERAPEUTICS PLC | $BCYC | Thompson Travis Alvin | CHIEF ACCOUNTING OFFICER | S | Ordinary Shares | 148 | $19.64 | 23,075.0000 | 51,992,034 | 0.64% | 0.00% |
| April 3, 2024 | BICYCLE THERAPEUTICS PLC | $BCYC | Thompson Travis Alvin | CHIEF ACCOUNTING OFFICER | S | Ordinary Shares | 152 | $23.81 | 23,223.0000 | 42,560,091 | 0.65% | 0.00% |
| Jan. 2, 2024 | BICYCLE THERAPEUTICS PLC | $BCYC | Thompson Travis Alvin | Chief Accounting Officer | A | Ordinary Shares | 16000 | $0.00 | 23,979.0000 | 35,592,362 | 200.53% | 0.04% |
| Jan. 3, 2024 | BICYCLE THERAPEUTICS PLC | $BCYC | Thompson Travis Alvin | Chief Accounting Officer | S | Ordinary Shares | 604 | $17.50 | 23,375.0000 | 35,592,362 | 2.52% | 0.00% |
| Jan. 2, 2024 | BICYCLE THERAPEUTICS PLC | $BCYC | Thompson Travis Alvin | Chief Accounting Officer | A | Employee Stock Option (right to buy) | 31000 | $0.00 | 31,000.0000 | 35,592,362 | 9999.99% | 0.09% |
| Oct. 3, 2023 | BICYCLE THERAPEUTICS PLC | $BCYC | Thompson Travis Alvin | Chief Accounting Officer | S | Ordinary Shares | 54 | $20.00 | 7,979.0000 | 39,576,467 | 0.67% | 0.00% |
| July 3, 2023 | BICYCLE THERAPEUTICS PLC | $BCYC | Thompson Travis Alvin | Chief Accounting Officer | S | Ordinary Shares | 61 | $25.10 | 8,033.0000 | 30,191,693 | 0.75% | 0.00% |